Dosing For Tumour-Induced Hypercalcaemia (TIH): 4 Mg Dosing And Administration | ZOMETA®

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

Zometa Dosing & Administration: Dosing for TIH

Treat tumour-induced hypercalcaemia with ZOMETA^® 4 mg

For patients with TIH, the recommended dose of ZOMETA is 4 mg¹
ZOMETA 4 mg should be reconstituted and further diluted with 100 mL 0.9% w/v sodium chloride or 5% w/v glucose solution¹
ZOMETA should be infused over no less than 15 minutes¹

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Treat tumour-induced hypercalcaemia with ZOMETA® 4 mg

Treat tumour-induced hypercalcaemia with ZOMETA^® 4 mg